N4 Pharma (LON:N4P) Shares Up 27.2% – Here’s Why

Shares of N4 Pharma Plc (LON:N4P) were up 27.2% during mid-day trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.67 ($0.01). Approximately 9,267,938 shares changed hands during trading, an increase of 322% from the average daily volume of 2,194,081 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Up 33.3 %

The company has a market cap of £2.76 million, a P/E ratio of -55.00 and a beta of -0.37. The company’s 50-day moving average is GBX 0.62 and its two-hundred day moving average is GBX 0.57. The company has a debt-to-equity ratio of 1.62, a current ratio of 22.73 and a quick ratio of 7.28.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.